| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,012 |
7,624 |
$527K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,606 |
3,206 |
$145K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
658 |
595 |
$4K |
| 93922 |
|
96 |
41 |
$4K |
| 82947 |
|
1,354 |
1,109 |
$4K |
| 36416 |
|
1,660 |
1,386 |
$3K |
| 80061 |
Lipid panel |
350 |
314 |
$3K |
| 93000 |
|
256 |
237 |
$3K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
345 |
296 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
59 |
57 |
$2K |
| 94761 |
|
1,975 |
1,476 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
65 |
59 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
99 |
90 |
$986.12 |
| 99406 |
|
84 |
73 |
$901.22 |
| 95923 |
|
28 |
20 |
$895.01 |
| 90688 |
|
79 |
74 |
$868.39 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
12 |
$851.15 |
| 99397 |
|
94 |
92 |
$812.83 |
| 95943 |
|
26 |
19 |
$811.48 |
| 82962 |
|
411 |
355 |
$684.99 |
| 36415 |
Collection of venous blood by venipuncture |
261 |
248 |
$538.81 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
13 |
$364.70 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
14 |
13 |
$319.62 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
123 |
116 |
$254.76 |
| 90756 |
|
16 |
16 |
$206.02 |
| 90694 |
|
13 |
13 |
$128.65 |
| 99497 |
|
58 |
57 |
$60.55 |
| S9999 |
Sales tax |
688 |
543 |
$54.62 |
| 94760 |
|
19 |
19 |
$6.87 |
| 3078F |
|
5,477 |
4,525 |
$2.82 |
| 3074F |
|
4,723 |
3,930 |
$2.64 |
| 1126F |
|
3,881 |
3,178 |
$2.09 |
| A4456 |
Adhesive remover, wipes, any type, each |
26 |
20 |
$1.63 |
| 1160F |
|
2,352 |
1,776 |
$1.56 |
| 1159F |
|
2,151 |
1,589 |
$1.54 |
| 1125F |
|
2,154 |
1,792 |
$1.01 |
| 3079F |
|
2,222 |
1,956 |
$0.99 |
| 3075F |
|
1,831 |
1,608 |
$0.69 |
| 3077F |
|
1,660 |
1,433 |
$0.54 |
| 3044F |
|
1,368 |
1,260 |
$0.44 |
| 4010F |
|
692 |
566 |
$0.30 |
| 3080F |
|
554 |
479 |
$0.25 |
| 1170F |
|
178 |
167 |
$0.02 |
| 3061F |
|
32 |
31 |
$0.01 |
| 1111F |
|
25 |
21 |
$0.01 |
| 2000F |
|
107 |
83 |
$0.00 |
| 3017F |
|
57 |
53 |
$0.00 |
| 1101F |
|
3,387 |
2,750 |
$0.00 |
| 1036F |
|
4,459 |
3,574 |
$0.00 |
| 3048F |
|
728 |
664 |
$0.00 |
| 3049F |
|
228 |
205 |
$0.00 |
| 1157F |
|
86 |
82 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
145 |
110 |
$0.00 |
| 3008F |
|
128 |
98 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
45 |
35 |
$0.00 |
| 4005F |
|
276 |
242 |
$0.00 |
| 1090F |
|
3,294 |
2,666 |
$0.00 |
| 4004F |
|
296 |
249 |
$0.00 |
| 3050F |
|
106 |
98 |
$0.00 |
| 0518F |
|
206 |
183 |
$0.00 |